main-img
Back to Home » October 2016 News » House panel: Mylan CEO minimized EpiPen profits in testimony

House panel: Mylan CEO minimized EpiPen profits in testimony

October 04, 2016

WASHINGTON (AP) -- Leaders of the House Oversight Committee want EpiPen maker Mylan to explain why the company's CEO apparently misled Congress about profits the company claimed for the life-saving EpiPen injection device....

Source URL: http://hosted.ap.org/dynamic/stories/U/US_CONGRESS_EPIPEN?SITE=ORLAG&SECTION=HOME&TEMPLATE=DEFAULT
Browse News